Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Primary Progressive Multiple Sclerosis (PPMS) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Myelin Regeneration in Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... the Myelin Regeneration in Multiple Sclerosis, historical and forecasted epidemiology as well as the Myelin Regeneration in Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Chronic Progressive Multiple Sclerosis – Market Insight, Epidemiology, and Market Forecast – 2034
... Progressive Multiple Sclerosis, historical and forecasted epidemiology as well as the Chronic Progressive Multiple Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Progressive Multiple ... Read More
-
Medical Exoskeleton Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others), and Geography
... Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare ... Read More
-
Intermittent Catheters Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory ... Read More
-
Multiple Sclerosis Therapeutics Market - 2024-2031
... forecast period 2024-2031. Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). With MS, the immune system mistakenly attacks myelin cells. These are the protective covers (sheaths) ... Read More
-
Multiple Sclerosis Therapeutics
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunomodulators, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$13.2 Billion by the ... Read More
-
Multiple Sclerosis Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 21.33 billion in 2023, and the market is now projected to grow from USD 21.16 billion in 2024 to USD 38.94 billion by 2032, exhibiting a CAGR of 7.9% during the forecast ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Neuroprotective Agents Market Size, Trends, Analysis, and Outlook By Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), By Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis, Others), By Route of Administration (Oral, Topical, Epidural, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032 The global Neuroprotective Agents market size is poised to register 7.2% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Neurodegenerative Disease Market Size, Trends, Analysis, and Outlook By Indication (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Others), By Drug (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Others), by Country, Segment, and Companies, 2024-2032
... Companies, 2024-2032 The global Neurodegenerative Disease market size is poised to register 7.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurodegenerative ... Read More
-
Autoimmune Treatment Market Size, Trends, Analysis, and Outlook By Drug Class(Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs, Interferons, Others), By Indication (Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital Pharmacy, Online, Others), by Country, Segment, and Companies, 2024-2032
... Segment, and Companies, 2024-2032 The global Autoimmune Treatment market size is poised to register 6.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Global Autoinjectors Market Size study & Forecast, by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User (Home Care Settings, Hospital and Clinics, and Others), and Regional Analysis, 2023-2030
... 2023-2030 Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices ... Read More
-
Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024
... growth prospects across the Secondary Progressive Multiple Sclerosis (SPMS) market. A detailed picture of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape is provided, which includes the disease overview and Secondary Progressive Multiple Sclerosis (SPMS) ... Read More
-
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024
... the Chronic Progressive Multiple Sclerosis market. A detailed picture of the Chronic Progressive Multiple Sclerosis pipeline landscape is provided, which includes the disease overview and Chronic Progressive Multiple Sclerosis treatment guidelines. The assessment part of ... Read More
-
Multiple sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2024
... the Relapsing Multiple Sclerosis (RMS) market. A detailed picture of the Relapsing Multiple Sclerosis (RMS) pipeline landscape is provided, which includes the disease overview and Relapsing Multiple Sclerosis (RMS) treatment guidelines. The assessment part of ... Read More
-
Injectable Cytotoxic Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 18.29 billion in 2023, and the market is now projected to grow from USD 19.03 billion in 2024 to USD 30.85 billion by 2032, exhibiting a CAGR of 6.2% during the forecast ... Read More
-
Digital Health in Neurology Market – By Component (Software, Hardware, Services), By Indication (Alzheimers Disease, Parkinsons Disease, Epilepsy, Multiple Sclerosis), By End-use (Patients, Providers, Payers) & Forecast (2024 – 2032)
... Market will witness over 19% CAGR between 2024 and 2032, propelled by the increasing number of partnerships and deals between leading companies. As key players join forces to combine their expertise and resources, they are ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Central Nervous System Disorders Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Depression Drugs, Multiple Sclerosis Drugs, Schizophrenia Drugs, Bipolar Disorder Therapeutics, Epilepsy Drugs, Others), By Drug Class (Analgesics, Antidepressant, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Central Nervous System Disorders Therapeutics market size is poised to register 6.94% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
Research Assistance
